Obstructive Sleep Apnoea Syndrome Clinical Trial
Official title:
Obstructive Sleep Apnoea and Associated Metabolic/Cardiovascular Disorders: Understanding Mechanisms Towards Early Diagnosis and Prognosis
Untreated Obstructive Sleep Apnea Syndrome (OSAS) has long-term complications, namely
metabolic imbalances (obesity, dislipidemia, type 2 diabetes mellitus). Until now, no
molecular markers for this physiopathological connection have been identified.
This project aims to determine non-invasive biomarkers that may allow better comprehension
of the metabolic consequences of OSAS, as well as assess the effect of Continuous positive
airway pressure (CPAP) on these metabolic parameters.
This project will integrate the clinical, metabolic, genetic/proteomic and biologic systems
to further explore the mechanisms behind OSAS, as well as the effect of the treatment with
CPAP.
n/a
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02515071 -
A 2 Week, Crossover Trial of Dietary Nitrate in Obstructive Sleep Apnoea Syndrome (OSAS).
|
N/A | |
| Completed |
NCT03701737 -
Study of Eating Behaviour and Sense of Taste Before and After Treatment With Nocturnal Continuous Positive Airway Pressure in Overweight Patients With Obstructive Sleep Apnea Syndrome.
|
||
| Completed |
NCT01282125 -
Nasal Obstruction in Sleep Apnea Patients Compared to the General Population
|
N/A |